How Often Does Ortho-K Actually Work?
Success rate is a slippery number in orthokeratology, because the answer depends entirely on how you define success. Set the bar at 20/20 in both eyes and the figure drops. Set it at functional unaided vision for daily life and it climbs. Set it at slowed axial elongation in a child and you are measuring something else altogether. Here is how we think about it, and why we do not put a single percentage in a headline.
On this page
What Success Means
What is the success rate of Ortho-K?
Published series generally report that most appropriately selected patients with low to moderate myopia achieve functional unaided daytime vision. The figure varies widely between studies because success is defined differently in each: some use 20/20, some use 20/40 or better, and some measure the reduction achieved rather than a visual acuity threshold.
We use three definitions in clinic and keep them separate. Visual success is whether you can do your day without correction. Refractive success is how much of your prescription was actually neutralized. Control success, for children, is whether axial elongation slowed against expectation. A patient can hit two of those and miss the third, which is exactly why a single headline number would mislead you.
Who Tends to Do Best
- Low to moderate myopia. The less corneal change required, the more predictable and complete the result.
- Limited astigmatism, and astigmatism that sits on the cornea. Corneal astigmatism can often be addressed in the design. Astigmatism originating behind the cornea generally cannot.
- Corneal shapes that hold a centered treatment zone. Centration is the single strongest predictor of a clean optical result.
- A healthy tear film and healthy lid margins. Both affect comfort, lens performance, and the optical quality of the reshaped surface.
- Consistent nightly wearers. The effect is maintained by the routine. Irregular wear produces irregular vision, and no design fixes that.
- Moderate pupil size in dim light. Large pupils are more likely to extend past the treated zone and pick up glare.
None of these are visible from a phone call. Topography is what turns a general expectation into a specific one, which is the point of the candidacy evaluation.
Where Results Fall Short
The most common shortfall is partial correction in a higher prescription: real improvement, but not enough to abandon glasses entirely. The second most common is a lens that decenters, which produces vision that is technically improved but optically unsatisfying, with ghosting or reduced contrast. The third is persistent end of day regression in a patient who needs sharp vision at 9 PM.
Each has a response. Decentration is usually addressed with a design change once the one week topography shows the drift. Regression can sometimes be improved by adjusting the target. Partial correction may simply be the ceiling for that eye, in which case the decision is whether the improvement earned is worth the nightly routine. We would rather have that conversation directly than let a patient quietly conclude the treatment failed. See Realistic Expectations.
Success in a Myopia Control Program
For a child, the vision result is the visible part and the least important one. What matters is whether the eye is still elongating, and how fast. Controlled studies of Ortho-K in children consistently report reduced axial elongation compared with single vision glasses or contacts, with the size of the effect varying between studies and between individuals.
Control is not the same as stopping progression. Some children continue to progress on treatment, just more slowly than they would have. That is still a meaningful clinical win, because the harm associated with myopia scales with how long the eye ends up. It is also why we chart axial length rather than relying on the annual prescription check. See Axial Length Monitoring.
Why We Do Not Publish One Percentage
A practice can produce almost any success rate it wants by choosing the definition and the patient population. Fit only low prescriptions, define success as 20/40 or better, and count only patients who completed the program, and you can publish a very impressive figure that tells a prospective patient nothing about their own eyes.
What we offer instead is a specific projection for your specific eyes at the consultation, based on your topography and refraction, expressed as a range with the reasoning explained. If the projection is poor, we tell you that and you do not buy lenses. See Clinical Evidence for how we read the published research.
Frequently Asked Questions
What percentage of patients are happy with the result?
In our experience the large majority of patients who complete a fitting continue with treatment, which is the most meaningful satisfaction signal available. Patients who are unhappy discontinue, and they can, because nothing is permanent.
We deliberately avoid publishing a satisfaction percentage, since any number we produced would come from our own patient mix and could not be independently verified by you.
Can you tell in advance whether it will work for me?
Largely, yes. Refraction, corneal topography, tear film assessment, and pupil measurement together give a well grounded projection.
The residual uncertainty is how your individual cornea responds to reshaping, which is only fully known after the first nights. The one week visit is where projection meets reality.
What happens if it does not work for me?
First we look for a fixable cause: decentration, an inadequate design, a tear film issue, or inconsistent wear. Most disappointing early results have one of those behind them.
If the ceiling is genuinely the eye rather than the design, we say so. You stop, the cornea returns to baseline, and you have lost the program investment rather than anything about your eyes.
Is it worth trying with a higher prescription?
Sometimes. Reducing a strong prescription substantially can transform daily life even if a light pair of glasses stays in the picture for night driving.
The decision should be made with a clear projected range in front of you, not on hope. If topography suggests the achievable reduction is small, we will recommend against it.
How does the success rate compare with other myopia control options?
Ortho-K, low dose atropine, and specially designed soft myopia control lenses all have supporting evidence, and the reported effect sizes overlap considerably.
Ortho-K has the distinguishing feature of correcting vision at the same time, so the child is glasses free during the day. See Ortho-K vs Atropine.
Keep reading
Last updated . Clinically reviewed by Dr. Mark Page.